Combination Treatment for Moderate to Severe Acne

Phase 4CompletedNCT01206348

Medicis Global Service Corporation97 enrolled

Overview

To determine if a combination of three currently approved acne products are safe and effective for the treatment of moderate to severe acne

A Phase IV, Open-Label Study Evaluating the treatment for Combination Acne Therapy.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Solodyn 1 tablet, Q day Ziana Gel, topical Q am Triaz FC, topical Q night

Sex: ALLMin age: 12 YearsMax age: 30 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * moderate to severe acne, IGA = 3 or 4 (Investigator Global Assessment) Exclusion Criteria: * pregnancy and allergies

Unnamed facility

Birmingham, Alabama, United States

Unnamed facility

Santa Monica, California, United States

Unnamed facility

Hockessin, Delaware, United States

Unnamed facility

Chestnut Hill, Massachusetts, United States

Proportion of patients showing improvement from Baseline and Week 12

Time frame: Week 12

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.